For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight ...

Lilly’s weight loss pill gained approval in April 2026, around three months after Novo Nordisk gained the same accolade for oral Wegovy.

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

A new study conducted among thousands of participants has found a daily target that may assist not only in weight loss, but also in preventing the recurrent weight regain that troubles many.

An experimental weight-loss injection, retatrutide, could soon become the most effective obesity medication on the market. In ...

Picture two 50-year-olds with the same education, the same neighborhood, and the same family history. One carries 30 extra ...

New research from the University of Georgia suggests that higher body mass index, or BMI, may be linked to faster cognitive decline in older adults. The finding adds to growing evidence that metabolic ...

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news relea ...

Nearly half of patients who got a high dose of Eli Lilly & Co.’s next-generation obesity shot lost the equivalent weight of ...

The pharma giant is taking steps to expand its portfolio.

If you are more invested in monitoring your health than tracking body fat percentage, the Withings Body Scan is truly a top ...

NEW YORK, May 21 (Reuters) - Eli Lilly said on Thursday that its experimental drug retatrutide helped patients diagnosed with obesity lose more than 28% of their weight over a year and a half in a key ...